SCOLARI, MARIA
 Distribuzione geografica
Continente #
AS - Asia 5.557
NA - Nord America 5.530
EU - Europa 4.555
AF - Africa 455
SA - Sud America 346
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.451
Nazione #
US - Stati Uniti d'America 5.430
SG - Singapore 1.589
VN - Vietnam 1.504
CN - Cina 1.351
GB - Regno Unito 1.085
IT - Italia 912
DE - Germania 548
SE - Svezia 548
HK - Hong Kong 396
UA - Ucraina 345
FR - Francia 275
BR - Brasile 246
IN - India 239
RU - Federazione Russa 203
IE - Irlanda 150
NL - Olanda 144
TG - Togo 139
ZA - Sudafrica 97
NG - Nigeria 88
JP - Giappone 85
FI - Finlandia 82
BD - Bangladesh 79
SC - Seychelles 70
CA - Canada 61
EE - Estonia 61
BG - Bulgaria 60
JO - Giordania 56
KR - Corea 48
AR - Argentina 45
CI - Costa d'Avorio 38
PH - Filippine 34
BE - Belgio 30
TH - Thailandia 28
IR - Iran 27
MX - Messico 25
TR - Turchia 24
IQ - Iraq 23
AT - Austria 20
CH - Svizzera 16
ES - Italia 15
GR - Grecia 15
TW - Taiwan 15
PL - Polonia 14
CO - Colombia 13
PK - Pakistan 12
EC - Ecuador 9
CL - Cile 8
MY - Malesia 8
PY - Paraguay 8
ID - Indonesia 7
VE - Venezuela 7
LT - Lituania 6
RO - Romania 6
UZ - Uzbekistan 6
AU - Australia 5
EG - Egitto 4
KZ - Kazakistan 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
MA - Marocco 3
OM - Oman 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
GH - Ghana 2
KE - Kenya 2
NP - Nepal 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
UY - Uruguay 2
AL - Albania 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
Totale 16.442
Città #
Singapore 1.096
Southend 949
Ashburn 663
Chandler 461
San Jose 418
Hong Kong 380
Ho Chi Minh City 332
Fairfield 280
Hanoi 274
Santa Clara 268
Jacksonville 235
Beijing 207
Princeton 193
Wilmington 181
Ann Arbor 163
Dublin 146
Houston 141
Lomé 139
Woodbridge 137
Seattle 122
Dong Ket 112
Boardman 108
Nanjing 105
Hefei 103
Los Angeles 94
Padova 94
Westminster 88
Abeokuta 86
Lauterbourg 85
Council Bluffs 82
Cambridge 79
Tokyo 77
Turin 77
New York 76
Helsinki 70
Berlin 67
Bologna 67
Milan 61
Sofia 59
Bremen 57
Amman 56
Medford 56
Buffalo 55
Haiphong 53
Jinan 51
Da Nang 49
Rome 43
Guangzhou 41
São Paulo 40
Munich 39
Saint Petersburg 39
Abidjan 38
Shenyang 36
Mülheim 33
Changsha 32
Hebei 31
Seoul 31
Redondo Beach 29
Brussels 27
Florence 27
Nanchang 27
Dallas 25
Redwood City 25
Chicago 24
Phoenix 24
The Dalles 24
Hangzhou 23
Zhengzhou 23
Dearborn 22
Frankfurt am Main 22
Tianjin 22
London 21
Bengaluru 20
Falkenstein 20
Mahé 20
Toronto 20
Jiaxing 19
Shanghai 19
San Diego 18
Hyderabad 17
Hải Dương 17
Taiyuan 16
Wuhan 16
Baghdad 14
Brooklyn 14
Fuzhou 14
Johannesburg 14
Mexico City 14
Monmouth Junction 14
Mountain View 14
Norwalk 14
Taizhou 14
Ningbo 13
Verona 13
Warsaw 13
Chennai 12
Montreal 12
Orem 12
Stockholm 12
Washington 12
Totale 9.947
Nome #
La conversione da MMF a Micofenolato sodico gastroprotetto (EC-MPS, Myfortic) migliora la sintomatologia gastrointestinale in pazienti con trapianto di rene in terapia con Tacrolimus 303
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 268
Advagraf vs Prograf immunosuppressive therapy in de novo kidney transplant: a single center experience 267
Correlazioni tra decoy cells urinarie, viremia BK e terapia immunosoppressiva nel trapianto di rene 266
A comparative study of renal preservation for the prevention of ischemia/reperfusion injury: Machine Perfusion versus Cold Storage in a porcine autotransplant model. 252
Anemia secondaria ad infezione da Parvovirus B19 nel trapianto renale 241
Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? 236
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury. 234
Delayed Graft Function (DGF) e Trapianto Renale: studio dei principali fattori di rischio. 230
COMBINED KIDNEY LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE 215
The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes 213
Impact of cytokines and apoptosis molecules polymorphisms on Chronic Allograft Nephropathy 212
Nephrological indications in combined liver kidney transplantation 211
INDICAZIONI NEFROLOGICHE AL TRAPIANTO COMBINATO RENE-FEGATO 209
Reduction of Oxidative Damage Reflects a Better Kidney Transplantation Outcome. 206
INFLUENCE OF DELAYED GRAFT FUNCTION (DGF) ON RENAL TRANSPLANTATION OUTCOME 205
Molecular markers in the early diagnosis of Acute Rejection after renal transplant 204
Differentiation of mesenchymal stem cells into renal precursors 202
Trapianto Combinato Rene-Fegato: Esperienza del Policlinico S.Orsola di Bologna 202
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 202
Incidence of cancer in kidney transplantation waiting list patients: a single center experience. 199
Doppio Trapianto Renale: Esperienza di un Centro Trapianti 198
Genetic Factors and Risk OF Acute Rejection in Kidney Transplant 197
Combined liver-kidney transplantation-s. Orsola experience: nephrological aspects. 197
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 195
Marcatori molecolari precoci di Rigetto Acuto nel Trapianto di Rene 194
A very early and acute renal impairment due to polyomavirus allograft nephropathy. 194
Effects of FTY720 on lymphocyte subsets expressing different homing receptors in kidney tranplantation 192
Schemi di terapia immunosoppressiva e livelli ematici consigliati 191
Incidenza di Rigetto Acuto nel Trapianto Renale: ruolo dei fattori genetici 189
Rigetto ed espressione di geni “housekeeping” nel Trapianto di Rene. 188
The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. 187
Cellule staminali mesenchimali in cloni di progenitori renali: fenotipo metanefrico 186
Chronic allograft dysfunction: role of immunosuppressive treatment 184
Epatopatia e trapianto renale: esperienza a medio-lungo termine 179
Score istologico pre-trapianto e outcome del trapianto renale 178
Efficacy and appropriateness of histological score in prediction of the 3-year outcome of kidney transplantation 178
Il Percorso di certificazione UNI EN ISO 9001:2000 di un Programma di Trapianto Renale. 177
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 177
Perfusione Continua versus Ipotermia Semplice nel Trapianto d’organo. Studio sperimentale su modello animale. 171
Influence of delayed graft function (DGF) on renal transplantation outcome 168
Nephrological indications in combined liver-kidney transplantation. 165
INCIDENCE OF LATE DEEP VENOUS THROMBOSIS IN RENAL TRANSPLANT RECIPIENTS 164
Expanding the Evidence Base in Transplantation: The Complementary Roles of Randomized Controlled Trials and Outcomes Research. 163
Trapianto di rene a Bologna 163
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 162
Fattori di rischio genetici per la patologia cardiovascolare dopo trapianto di rene: ruolo dei polimorfismi delle citochine 161
Il Trapianto Combinato Rene-Fegato: esperienza monocentrica a lungo termine 161
Metabolic syndrome after kidney transplantation. 161
Therapy strategies in the prevention of chronic allograft nephropathy 160
Double kidney transplantation: initial experience of the Bologna Transplant Center. 160
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin. 160
Chronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitors 159
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study. 159
Predictive factors in chronic allograft nephropathy 159
FTY720 nel trapianto renale: caratterizzazione molecolare dei processi di homing dei linfociti circolanti 157
Genetic variability and cardiovascular risk in renal transplant recipients 156
Role of killer-cell immunoglobulin-like receptor and human leucocyte antigen in kidney transplantation 156
Term placenta human mesenchymal stem cells treated with butyric and hyaluronic esters express markers for metanephric differentiation and protect against ischemia-reperfusion kidney injury in rats 155
Expression of metanephric differentiation markers in human mesenchymal stem cells. [Marker di differenziamento metanefrico espressi in cellule staminali mesenchimanli umane]. 153
Factors determining cardiovascular disease progression after kidney transplant 153
Combined liver kidney transplantation: St. Orsola experience 152
Prevenire e ridurre le comorbilità nei candidati per aumentare la durata del rene trapiantato 149
Killer-cell immunoglobulin-like receptor genes and ligands in kidney transplant 149
INFLUENCE OF APOPTOSIS AND INFLAMMATION GENE POLYMORPHISMS ON TRANSPLANTED KIDNEY FUNCTION 147
Potenziali applicazioni delle cellule staminali nelle patologie renali: impiego di molecole sintetiche per il differenziamento in progenitori renali 146
GENETIC FACTORS AND RISK OF CHRONIC ALLOGRAFT NEPHROPATHY IN KIDNEY TRANSPLANT 145
Low-toxicity immunosuppressive therapy in renal transplant. [Il successo del trapianto di rene dipende anche da una terapia efficace a bassa tossicità]. 144
Tacrolimus-associated myositis: a case report in a renal transplant patient. 141
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 140
Prospective study on the clinical and prognostic significance of Polyomavirus JC infection in kidney transplant 139
Oxidative stress in kidney transplant recipients 138
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 137
Incidenza di Nefropatia Cronica da Trapianto: possibile ruolo dei polimorfismi genetici di citochine infiammatorie e di molecole di apoptosi 137
Kidney transplantation in highly immunized patients: ten years of follow-up 137
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 136
Long-term results of combined Liver-Kidney Transplantation: a single-center experience 136
Increase of T cell subsets expressing markers of activation and cytoxicity in patients with post-transplant malignancy 134
IMPACT OF CYTOKINE AND APOPTOSIS GENE POLYMORPHISMS ON ACUTE GRAFT REJECTION AFTER KIDNEY TRANSPLANT 133
Advantages and challenges for use of Registries for transplant outcomes research 133
Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review. 133
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 131
La valutazione clinica del donatore vivente 124
NGAL as a marker of renal damage in kidney transplantation 124
Genetic variability and cardiovascular risk in renal transplant recipients 123
Preliminary results from a prospective multicenter study reveal the early appearance of de novo anti-HLA antibodies following renal transplantation 101
Immune response following fresh arterial homograft replacement for aortoiliac graft infection 84
Miglioramento della sintomatologia gastrointestinale in pazienti con trapianto renale stabile dopo conversione da MMF a Micofenolato sodico gastroprotetto (EC-MPS, Myfortic) 75
ELISA anti-HLA antibody screening identifies non-complement-fixing antibodies responsible for acute graft rejection. A case report 74
Is Ace inhibitor treatment a possible cause of better cardiovascular remodelling in well functioning kidney transplant? 74
Randomized trial of sodium mycophenolate (MPS) and basiliximab in combination with reduced or standard cyclosporine (CsA) in old recipents of kydney transplant (KTX) 73
Membranes, technologies and long-term results in chronic haemodialysis 72
Review of 20 years' clinical experience with living donor kidney transplantation at the Polyclinic of St. Orsola 71
Preventing and reducing comorbidity in candidates for kidney transplantation for the improvement of post-operative results 71
Sudeck's atrophy of the left tibiotarsal joint in a renal transplant patient: Effects of medical and physical therapy 71
Mismatch-specific anti-HLA antibody production following aorta transplants 69
Funzione ritardata del trapianto renale da danno ischemico reversibile. Fattori di rischio e prognosi a breve e a lungo termine 66
[Renal transplantation and malignancies: A single-centre experience (25 years)] 64
Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience 51
Application of flow cytometry in clinical renal transplantation 50
Totale 16.058
Categoria #
all - tutte 40.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 0 0 0 0 0 0 0 361
2021/20221.629 164 119 96 124 149 111 20 86 51 83 325 301
2022/20232.188 213 371 126 262 190 168 64 97 351 62 204 80
2023/2024603 34 77 32 87 50 139 33 55 7 30 16 43
2024/20252.402 91 316 191 127 425 121 212 87 45 195 40 552
2025/20265.656 432 426 406 342 731 364 517 252 1.199 485 252 250
Totale 16.641